Pharma stock under Rs 65 is in the green as Board allots 52,52,190 equity shares to non-promoters post-stock split!
Pharma stock under Rs 65 is in the green as Board allots 52,52,190 equity shares to non-promoters post-stock split!

Pharma stock under Rs 65 is in the green as Board allots 52,52,190 equity shares to non-promoters post-stock split!

From Rs 35.03 per share (52-week low) to Rs 60.09 per share, the stock is up by 71.5 per cent and gave multibagger returns of 110 per cent in 2 years.

Kiran Shroff Article rating: 4.6

From Rs 35.03 per share (52-week low) to Rs 60.09 per share, the stock is up by 71.5 per cent and gave multibagger returns of 110 per cent in 2 years.

Multibagger pharma stock under Rs 65 is in the green as the company launches its new product lines, PureCoat and UltraMod; Details inside!
Multibagger pharma stock under Rs 65 is in the green as the company launches its new product lines, PureCoat and UltraMod; Details inside!

Multibagger pharma stock under Rs 65 is in the green as the company launches its new product lines, PureCoat and UltraMod; Details inside!

From Rs 35.03 per share (52-week low) to Rs 62.49 per share, the stock is up by 78.4 per cent and gave multibagger returns of 115 per cent in 2 years.

Kiran Shroff Article rating: 3.7

From Rs 35.03 per share (52-week low) to Rs 62.49 per share, the stock is up by 78.4 per cent and gave multibagger returns of 115 per cent in 2 years.

Multibagger pharma stock under Rs 65 to keep under the radar as Board announces cutoff date for final dividend!
Multibagger pharma stock under Rs 65 to keep under the radar as Board announces cutoff date for final dividend!

Multibagger pharma stock under Rs 65 to keep under the radar as Board announces cutoff date for final dividend!

From Rs 33.30 per share (52-week low) to Rs 61.25 per share, the stock is up by 84 per cent and gave multibagger returns of 130 per cent in 2 years. I

Kiran Shroff Article rating: 4.7

From Rs 33.30 per share (52-week low) to Rs 61.25 per share, the stock is up by 84 per cent and gave multibagger returns of 130 per cent in 2 years. I

Multibagger pharma stock under Rs 70 to keep under the radar as company announces positive quarterly results (Q1FY25)
Multibagger pharma stock under Rs 70 to keep under the radar as company announces positive quarterly results (Q1FY25)

Multibagger pharma stock under Rs 70 to keep under the radar as company announces positive quarterly results (Q1FY25)

From Rs 33.30 per share (52-week low) to Rs 63.79 per share, the stock is up by 91.6 per cent and gave multibagger returns of 156 per cent in 2 years.

Kiran Shroff Article rating: 3.7

From Rs 33.30 per share (52-week low) to Rs 63.79 per share, the stock is up by 91.6 per cent and gave multibagger returns of 156 per cent in 2 years.

10:1 stock split in FY24: Multibagger pharma stock under Rs 70 zooms over 9 per cent in just 1 day with 8 times spurt in volume; Keep under the radar!
10:1 stock split in FY24: Multibagger pharma stock under Rs 70 zooms over 9 per cent in just 1 day with 8 times spurt in volume; Keep under the radar!

10:1 stock split in FY24: Multibagger pharma stock under Rs 70 zooms over 9 per cent in just 1 day with 8 times spurt in volume; Keep under the radar!

From Rs 29.32 per share (52-week low) to Rs 65.85 per share, the stock gave multibagger returns of 124.6 per cent.

Kiran Shroff Article rating: 3.7

From Rs 29.32 per share (52-week low) to Rs 65.85 per share, the stock gave multibagger returns of 124.6 per cent.

Multibagger pharma stock under Rs 80 & 10:1 stock split in FY24: Company announced stellar FY24 results; PAT zooms over 100 per cent
Multibagger pharma stock under Rs 80 & 10:1 stock split in FY24: Company announced stellar FY24 results; PAT zooms over 100 per cent

Multibagger pharma stock under Rs 80 & 10:1 stock split in FY24: Company announced stellar FY24 results; PAT zooms over 100 per cent

. From Rs 23.3 per share (52-week low) to Rs 75.45 per share, the stock gave multibagger returns of 224 per cent.

Kiran Shroff Article rating: 3.7

. From Rs 23.3 per share (52-week low) to Rs 75.45 per share, the stock gave multibagger returns of 224 per cent.

10:1 Stock Split: Heavy buying witnessed in this multibagger pharma stock under Rs 75; FIIs bought a 1.97 per cent stake!
10:1 Stock Split: Heavy buying witnessed in this multibagger pharma stock under Rs 75; FIIs bought a 1.97 per cent stake!

10:1 Stock Split: Heavy buying witnessed in this multibagger pharma stock under Rs 75; FIIs bought a 1.97 per cent stake!

From Rs 23.16 per share (52-week low) to Rs 70.39 per share, the stock gave multibagger returns of over 200 per cent.

Kiran Shroff Article rating: 4.0

From Rs 23.16 per share (52-week low) to Rs 70.39 per share, the stock gave multibagger returns of over 200 per cent.

10:1 Stock Split: FIIs bought 27,73,291 shares of this multibagger pharma stock below Rs 75; Board allocated 47,18,080 equity shares to non-promoters via preferential issue!
10:1 Stock Split: FIIs bought 27,73,291 shares of this multibagger pharma stock below Rs 75; Board allocated 47,18,080 equity shares to non-promoters via preferential issue!

10:1 Stock Split: FIIs bought 27,73,291 shares of this multibagger pharma stock below Rs 75; Board allocated 47,18,080 equity shares to non-promoters via preferential issue!

From Rs 22 per share (52-week low) to Rs 70.17 per share, the stock gave multibagger returns of over 200 per cent.

Kiran Shroff Article rating: 3.9

In December 2023, Foreign Institutional Investors (FIIs) bought 27,73,291 shares of this company and increased their stake to 1.82 per cent from 0.95 per cent in September 2023.

USD 5,40,00,000 revenue aim by 2029 in this multibagger penny stock: This small-cap pharma company announces joint venture with iMass Investment in the UAE
USD 5,40,00,000 revenue aim by 2029 in this multibagger penny stock: This small-cap pharma company announces joint venture with iMass Investment in the UAE

USD 5,40,00,000 revenue aim by 2029 in this multibagger penny stock: This small-cap pharma company announces joint venture with iMass Investment in the UAE

From Rs 22 per share (52-week low) to Rs 94.40 per share (52-week high), the stock gave multibagger returns of 329 per cent.

Kiran Shroff Article rating: 3.1

From Rs 22 per share (52-week low) to Rs 94.40 per share (52-week high), the stock gave multibagger returns of 329 per cent.

All-time high multibagger penny stock at Rs 88 & FIIs bought 27,73,291 shares: Heavy buying witnessed in this pharma stock; hit 52-week high on February 24
All-time high multibagger penny stock at Rs 88 & FIIs bought 27,73,291 shares: Heavy buying witnessed in this pharma stock; hit 52-week high on February 24

All-time high multibagger penny stock at Rs 88 & FIIs bought 27,73,291 shares: Heavy buying witnessed in this pharma stock; hit 52-week high on February 24

The stock gave multibagger returns of 235 per cent in just 1 year and up 300 per cent from its 52-week low of Rs 21.98 per share.

Kiran Shroff Article rating: 3.7

The stock gave multibagger returns of 235 per cent in just 1 year and up 300 per cent from its 52-week low of Rs 21.98 per share.

All-time high multibagger penny stock at Rs 87: FIIs bought 27,73,291 shares of this pharma company after stock split from Rs 10 to Rs 1
All-time high multibagger penny stock at Rs 87: FIIs bought 27,73,291 shares of this pharma company after stock split from Rs 10 to Rs 1

All-time high multibagger penny stock at Rs 87: FIIs bought 27,73,291 shares of this pharma company after stock split from Rs 10 to Rs 1

The stock gave multibagger returns of 226.5 per cent in just 1 year and up 300 per cent from its 52-week low of Rs 21.98 per share.

Kiran Shroff Article rating: 3.4

The company ex-traded the stock split of equity shares from Rs 10 to Rs 1 on October 09, 2023.

DSIJ MINDSHARE

Mkt Commentary21-Nov, 2024

Multibaggers21-Nov, 2024

Mindshare21-Nov, 2024

Mindshare21-Nov, 2024

Mindshare21-Nov, 2024

Knowledge

MF15-Nov, 2024

General15-Nov, 2024

MF14-Nov, 2024

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR